Organization
UT Health Sciences Center at Houston
3 abstracts
Abstract
Gemcitabine/paclitaxel/adriamycin (GTA) as a nephron-sparing regimen in urothelial carcinoma: The MD Anderson Cancer Center (MDACC) experience.Org: UT Health Sciences Center at Houston,
Abstract
Diagnostic performance of natural language processing in detection of acute cancer VTE.Org: University of Texas MD Anderson Cancer Center, UT Health Sciences Center at Houston, The University of Texas Health Science Center McGovern Medical School, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Department of Analytics and Informatics,
Abstract
Clinical outcomes of patients with multiple myeloma following disease progression after BCMA-targeted CAR T-cell therapy.Org: Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, UT Health Sciences Center at Houston, University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,